Daniel Faga
2023
In 2023, Daniel Faga earned a total compensation of $7.5M as President and Chief Executive Officer and Director at ANAPTYSBIO, a 69% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $352,333 |
|---|---|
| Option Awards | $3,287,320 |
| Salary | $640,605 |
| Stock Awards | $1,658,622 |
| Other | $1,523,040 |
| Total | $7,461,920 |
Faga received $3.3M in option awards, accounting for 44% of the total pay in 2023.
Faga also received $352.3K in non-equity incentive plan, $640.6K in salary, $1.7M in stock awards and $1.5M in other compensation.
Rankings
In 2023, Daniel Faga's compensation ranked 40th out of 2,978 executives tracked by ExecPay. In other words, Faga earned more than 98.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 40 out of 2,978 | 99th |
Division Manufacturing | 19 out of 1,637 | 99th |
Major group Chemicals And Allied Products | 14 out of 906 | 99th |
Industry group Drugs | 13 out of 869 | 99th |
Industry Pharmaceutical Preparations | 7 out of 627 | 99th |
Source: SEC filing on April 24, 2024.
Faga's colleagues
We found two more compensation records of executives who worked with Daniel Faga at ANAPTYSBIO in 2023.